Johan Engdahl

Cardiologist and AF discoverer at Danderyd Hospital

[Johan Engdahl @JohanEngdahl2]

We are proudly looking forward to the presentation of the STROKESTOP 2 study by Katrin Kemp Gudmundsdottir on sunday september 1st, #ESCCongress hotline 9. Many thanks to the 6868 participants from the Stockholm region and Roche Diagnostics for inspiring collaboration.

[Johan Engdahl @JohanEngdahl2]

Happy to invite all interested in the future of heart rhythm monitoring to Dr Jonatan Fernstads presentation on large-scale data of machine learning reading of smartphone PPG, ESC congress Saturday 31st at Science Box 2 - Research Gateway.

https://t.co/qWFGh1dkq7

#ESCCongress

[Johan Engdahl @JohanEngdahl2]

@Dominik_Linz @SZDiederichsen @RachelvdVelden_ @harry_crijns @EmmaSvennberg Good luck from Danderyd Hospital!

[Johan Engdahl @JohanEngdahl2]

Validation of a novel smartphone-based photoplethysmographic method for ambulatory heart rhythm diagnostics https://t.co/EiDLcwAOdH

Heart rhythm recording using smartphone photopletysmography (PPG) has an enormous potential given the device availability.

[NEJM @NEJM]

Presented at #ACC24:

Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: https://t.co/z1NNeAK9Mm

[Johan Engdahl @JohanEngdahl2]

The STROKESTOP publication pedigree, with a few more to come. Happy Easter!

[William F McIntyre @WFMMD]

@SidPatelMD @CircAHA Thank you for your balanced and insightful editorial.

[Dan Atar @dan_atar]

For you interested in AFib and rhythm-versus-rate control:
Hold the date of the public scientific defense of dr. Marita K. Pope, our MD-PhD-candidate.
April 22nd, 2024.
Trial Lecture at 10:15 and defense at 13:15.
‘Gamle Festsal’ of the University of Oslo, next to the Aula.

[Johan Engdahl @JohanEngdahl2]

https://t.co/gHOVLTEJzT
Very well formulated editorial by Lars Wallentin and Robert Giugliano on the FRAIL AF study!

[Johan Engdahl @JohanEngdahl2]

ISC 2024: Data from STROKE AF study show cost effectiveness of ICM in ischaemic stroke patients https://t.co/q9y0jMQzqj I believe this cost effectiveness analysis would have been strengthened with outcomes.

[Johan Engdahl @JohanEngdahl2]

Randomised, siteless study to compare systematic atrial fibrillation screening using enrichment by a risk prediction model with standard care in a Swedish population aged ≥ 65 years: CONSIDERING-AF study design @BMJ_Open https://t.co/bjHPvuhfet

[Johan Engdahl @JohanEngdahl2]

@trygve_berge @AfibNo @MariamAnjumMD @ESC_Journals Congratulations Trygve to the results of a well-needed study!

[Johan Engdahl @JohanEngdahl2]

Finally, we publish the study design of the secondary preventive AF screening study AF SPICE! Study commenced inclusion in january 2022. Nice to hear any comments from you. https://t.co/EGbplzLaoB

[C. Michael Gibson MD @CMichaelGibson]

BREAKING

OCEANIC-AF study stopped early due to lack of efficacy

Independent Data Monitoring Committee (IDMC) recommends stopping the OCEANIC-AF study due to inferior efficacy of #asundexian vs apixaban in atrial fibrillation https://t.co/akEW7Uas9g

[Johan Engdahl @JohanEngdahl2]

Amazing PhD defense from Anna Thorén at Danderyds Hospital today, with her Thesis on Prediction and Monitoring of in-hospital cardiac arrest. Many congrats!

[Johan Engdahl @JohanEngdahl2]

@lsjMD After reading meta-analysis, yes!

[William F McIntyre @WFMMD]

With @ARTESIA_RCT presented at #AHA23 this AM, many are working to reconcile the positive results with those from NOAH @afnet_ev 6 from #ESC2023. This meta-analysis does just that. The trials are totally consistent: https://t.co/lOb1IxtaB3 #EPeeps

[Johan Engdahl @JohanEngdahl2]

What Lies beneath the Surface — Treatment of Subclinical Atrial Fibrillation | NEJM https://t.co/dXUlI5DBLs

You have to read the Artesia editorial by @EmmaSvennberg !

[Johan Engdahl @JohanEngdahl2]

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation | NEJM Amazing results from Artesia. https://t.co/IU4VglEzU4

[Johan Engdahl @JohanEngdahl2]

@lsjMD Thanks, Linda!